Free Trial

Health Sciences Acquisitions Co. 2 (HSAQ) Competitors

Health Sciences Acquisitions Co. 2 logo
$2.71 -0.13 (-4.58%)
As of 08/28/2025

HSAQ vs. NSPR, CTCX, TMDIF, RVP, PETV, GBS, BTCY, IVF, DYNT, and TTOO

Should you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), Retractable Technologies (RVP), PetVivo (PETV), GBS (GBS), Biotricity (BTCY), INVO Fertility (IVF), Dynatronics (DYNT), and T2 Biosystems (TTOO). These companies are all part of the "surgical & medical instruments" industry.

Health Sciences Acquisitions Co. 2 vs. Its Competitors

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

InspireMD has a consensus target price of $4.50, indicating a potential upside of 84.43%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Health Sciences Acquisitions Co. 2.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Sciences Acquisitions Co. 2
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
InspireMD
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, InspireMD had 2 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 3 mentions for InspireMD and 1 mentions for Health Sciences Acquisitions Co. 2. Health Sciences Acquisitions Co. 2's average media sentiment score of 0.00 equaled InspireMD'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health Sciences Acquisitions Co. 2
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
InspireMD
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat InspireMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Sciences Acquisitions Co. 2N/A N/A -2.38%
InspireMD -413.96%-69.42%-57.68%

Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500.

Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than InspireMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/A
InspireMD$7.07M14.41-$19.92M-$0.83-2.94

89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Comparatively, 29.7% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

InspireMD beats Health Sciences Acquisitions Co. 2 on 7 of the 12 factors compared between the two stocks.

Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSAQ vs. The Competition

MetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$30.39M$80.11M$5.76B$9.75B
Dividend YieldN/AN/A3.95%4.02%
P/E RatioN/A11.5431.4526.39
Price / SalesN/A100.48431.75159.28
Price / CashN/A18.4137.7559.42
Price / Book-4.378.2610.566.59
Net Income-$380K-$26.39M$3.27B$265.83M
7 Day Performance8.84%0.84%0.61%0.18%
1 Month Performance-20.29%3.23%5.43%2.13%
1 Year Performance-58.18%76.42%50.37%21.07%

Health Sciences Acquisitions Co. 2 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSAQ
Health Sciences Acquisitions Co. 2
N/A$2.71
-4.6%
N/A-56.2%$30.39MN/A0.004
NSPR
InspireMD
3.378 of 5 stars
$2.47
+2.9%
$4.50
+82.2%
-14.8%$103.05M$7.07M-3.2950Gap Up
High Trading Volume
CTCX
Carmell
N/A$2.70
+3.6%
N/A+403.6%$56.44M$32.84K0.0014News Coverage
TMDIF
Titan Medical
N/A$0.31
-12.9%
N/A+667.5%$35.66M$17.63M-0.2550Gap Down
RVP
Retractable Technologies
1.5146 of 5 stars
$0.84
-0.9%
N/A-10.0%$25.18M$38.16M-1.56240Positive News
PETV
PetVivo
N/A$0.80
+0.2%
N/A+33.3%$22.32M$1.05M-1.7820Gap Up
GBS
GBS
N/A$1.47
-0.7%
N/A+23.3%$21.89MN/A-2.627News Coverage
Gap Down
BTCY
Biotricity
N/A$0.57
-12.9%
N/A+46.2%$14.18M$12.06M-0.5340News Coverage
Gap Up
High Trading Volume
IVF
INVO Fertility
N/A$1.01
-9.8%
N/A-96.6%$4.89M$6.53M-0.0125Gap Down
DYNT
Dynatronics
N/A$0.09
+5.6%
N/A-43.1%$1.19M$33.60M-0.11200Gap Down
TTOO
T2 Biosystems
N/A$0.01
+18.2%
N/A-99.9%$274K$7.68M0.00180Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:HSAQ) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners